Ces Urol 2026, 30(2):77-83 | DOI: 10.48095/cccu2026012

Erectile dysfunction – a retrospective statistical analysis

Aneta Hujová1, Marek Broul1,2,3
1 Fakulta zdravotnických studií UJEP v Ústí nad Labem
2 Sexuologické oddělení, Krajská zdravotní, a.s. – Masarykova nemocnice v Ústí nad Labem, o.z.
3 Urologické oddělení, Krajská zdravotní, a.s. – Nemocnice Litoměřice, o.z.

Major statement: This study evaluates the prevalence and risk factors of erectile dysfunction in a retrospective male cohort, identifying age and body mass index as independent predictors. The findings highlight substantial underdiagnosis and emphasize the need for multidisciplinary prevention and management.

Aim: The aim of the study was to retrospectively analyze the occurrence of erectile dysfunction (ED), its coded dominant etiology, and selected associated factors, particularly age, body mass index, and the use of selected medication groups, in men examined at a single specialized sexology center in the Ústí nad Labem Region.

Material and Methods: This was a retrospective observational analysis of secondary data obtained from the hospital information system of the Department of Sexology, Masaryk Hospital in Ústí nad Labem. Men aged ≥ 18 years who were examined for ED at their first outpatient visit between January 1, 2021, and December 31, 2024, were included. The type of ED was derived from clinical documentation, where it had been established by a physician during the initial evaluations. Based on this previously coded dominant etiology, patients were classified into organic ED (N48.4) or psychogenic ED (F52.2) according to the revision of the International Classification of Diseases (ICD-10).

Results: A total of 2,901 men were analyzed, with a mean age 50.47 ± 12.79 years. Psychogenic ED was coded in 52.77% of patients and organic ED in 47.23%. Body mass index data were available for 93.83% of the cohort, when more than 80% of patients were overweight or obese. Selected medication groups were used by 27.13% of patients, most commonly antihypertensives. In multivariable logistic regression analysis, body mass index (OR 1.22; 95% CI 1.01-1.48; p = 0.045) and age (OR 1.01; 95% CI 1.00-1.01; p = 0.024) were significantly associated with ED category, whereas the use of the selected medications was not. However, the magnitude of these associations was relatively small.

Conclusion: This regional cohort of men with ED shows a high prevalence of overweight and obesity and significant differences in the distribution of ED type across age categories. Age and body mass index were independently associated with coded ED etiology, whereas the use of selected medication groups was not. The interpretation of differences between etiological groups is limited by the classification based on the initial clinical assessment. The findings support the need for systematic cardiometabolic screening in men with ED.

Keywords: body mass index – erectile dysfunction – obesity – age – cardiometabolic factors

Received: March 1, 2026; Revised: April 17, 2026; Accepted: May 11, 2026; Prepublished online: June 19, 2026; Published: June 22, 2026 


References

  1. Sivaratnam L, Selimin DS, Abd Ghani SR et al. Behavior-related erectile dysfunction: a systematic review and meta-analysis. J Sex Med 2021; 18(1): 121-143. doi: 10.1016/j.jsxm.2020.09.009. Go to original source...
  2. European Association of Urology. EAU Guidelines on Sexual and Reproductive Health. Arnhem: EAU Guidelines Office 2025. [online]. Available from: https://uroweb.org/guidelines/sexual-and-reproductive-health.
  3. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84(1): 50-56. doi: 10.1046/j.1464-410x.1999.00142.x. Go to original source...
  4. Wang CM, Wu BR, Xiang P et al. Management of male erectile dysfunction: from the past to the future. Front Endocrinol (Lausanne) 2023; 14: 1148834. doi: 10.3389/fendo.2023.1148834. Go to original source... Go to PubMed...
  5. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007; 120(2): 151-157. doi: 10.1016/j.amjmed.2006.06.010. Go to original source... Go to PubMed...
  6. Dilixiati D, Waili A, Tuerxunmaimaiti A et al. Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 2024; 15: 1368079. doi: 10.3389/fendo.2024.1368079. Go to original source... Go to PubMed...
  7. Huang K, Yin S, Xiao Y et al. Sexual dysfunction in patients with diabetes: association between remnant cholesterol and erectile dysfunction. Lipids Health Dis 2024; 23(1): 55. doi: 10.1186/s12944-024-02046-8. Go to original source...
  8. Defeudis G, Mazzilli R, Di Tommaso AM et al. Effects of diet and antihyperglycemic drugs on erectile dysfunction: a systematic review. Andrology 2023; 11(2): 282-294. doi: 10.1111/andr.13192. Go to original source... Go to PubMed...
  9. Feng L, Jinhua W, Shulin G et al. Causal association between antidiabetic drugs and erectile dysfunction: evidence from Mendelian randomization. Front Endocrinol (Lausanne) 2024; 15: 1414958. doi: 10.3389/fendo.2024.1414958. Go to original source... Go to PubMed...
  10. Sarma AV, Hotaling JM, de Boer IH et al. Blood pressure, antihypertensive medication use, and risk of erectile dysfunction in men with type i diabetes. J Hypertens 2019; 37(5): 1070-1076. doi: 10.1097/HJH.0000000000001988. Go to original source... Go to PubMed...
  11. Zhao C, Feng JL, Deng S et al. Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a mendelian randomization study. Front Cardiovasc Med 2023; 10: 1157467. doi: 10.3389/fcvm.2023.1157467. Go to original source... Go to PubMed...
  12. Liu Q, Zhang Y, Wang J et al. Erectile dysfunction and depression: a systematic review and meta-analysis. J Sex Med 2018; 15(8): 1073-1082. doi: 10.1016/j.jsxm.2018.05.016. Go to original source... Go to PubMed...
  13. Alswat KA, Almorgi Z, Aljardahi AN et al. Erectile dysfunction and depression prevalence among male patients with type II diabetes. J Multidiscip Healthc 2024; 17: 2041-2051. doi: 10.2147/JMDH.S455089. Go to original source... Go to PubMed...
  14. Dai H, Wang J, Zhao Q et al. Erectile dysfunction and associated risk factors in male patients with ischemic stroke: a cross-sectional study. Medicine (Baltimore) 2020; 99(1): e18583. doi: 10.1097/MD.0000000000018583. Go to original source...
  15. Pozzi E, Fallara G, Capogrosso P et al. Primary organic versus primary psychogenic erectile dysfunction: findings from a real-life cross-sectional study. Andrology 2022; 10(7): 1302-1309. doi: 10.1111/andr.13212. Go to original source...
  16. Broul M, Hujová A. Late-onset hypogonadism in men over 40 - how to use the updated EAU 2025 guidelines and new findings on the cardiovascular safety of testosterone therapy. Cas Lek Cesk 2025; 164(4): 150-155.
  17. Broul M, Kučerová P, Jozífková E et al. Treatment of thyroid disorder supported by 5-phosphodiesterase inhibitors improved erectile dysfunction in patients with hypo- and hyperthyroidism. Neuro Endocrinol Lett 2024; 45(3): 180-187.
  18. Broul M, Hujová A, Radovnická L et al. Hyperprolactinemia-associated erectile dysfunction: retrospective cohort evaluating the effect of prolactin normalization on IIEF-5. Neuro Endocrinol Lett 2025; 46(2): 107-114.
  19. Köhler TS, Kloner RA, Rosen RC et al. The princeton IV consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2024; 99(9): 1500-1517. doi: 10.1016/j.mayocp.2024.06.002. Go to original source... Go to PubMed...
  20. MKN-10 2026. MKN-10 klasifikace. [online]. Dostupné z: https://mkn10.uzis.cz.
  21. Esposito K, Giugliano F, Di Palo C et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291(24): 2978-2984. doi: 10.1001/jama.291.24.2978. Go to original source... Go to PubMed...
  22. Broul M, Hujová A, Liegertová M. Advances in the diagnosis and treatment of male infertility - an overview of current methods. Cas Lek Cesk 2025; 164(2): 43-49.
  23. Národní zdravotnický informační portál (NZIP). Erektilní dysfunkce (poruchy erekce, impotence). [online]. Dostupné z: https://www.nzip.cz/clanek/426-poruchy-erekce-erektilni-dysfunkce.





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit